383 related articles for article (PubMed ID: 11306464)
1. Androgen receptor stabilization in recurrent prostate cancer is associated with hypersensitivity to low androgen.
Gregory CW; Johnson RT; Mohler JL; French FS; Wilson EM
Cancer Res; 2001 Apr; 61(7):2892-8. PubMed ID: 11306464
[TBL] [Abstract][Full Text] [Related]
2. Immunohistochemical and in situ hybridization studies of androgen receptor expression in a transplantable androgen-independent prostatic carcinoma line (AIT) of Noble rats.
Leav I; Kwan PW; Merk FB; Chang C; Ho SM
Lab Invest; 1992 Dec; 67(6):788-95. PubMed ID: 1460869
[TBL] [Abstract][Full Text] [Related]
3. Stimulation of apolipoprotein D secretion by steroids coincides with inhibition of cell proliferation in human LNCaP prostate cancer cells.
Simard J; Veilleux R; de Launoit Y; Haagensen DE; Labrie F
Cancer Res; 1991 Aug; 51(16):4336-41. PubMed ID: 1868457
[TBL] [Abstract][Full Text] [Related]
4. Basal and estrogen-stimulated hormone receptor profiles in four R3327 rat prostatic carcinoma sublines in relation to histopathology and androgen sensitivity.
Mobbs BG; Johnson IE
Cancer Res; 1988 Jun; 48(11):3077-83. PubMed ID: 3259159
[TBL] [Abstract][Full Text] [Related]
5. Testosterone-mediated increase in 5 alpha-dihydrotestosterone content, nuclear androgen receptor levels, and cell division in an androgen-independent prostate carcinoma of Noble rats.
Ho SM; Leav I; Damassa D; Kwan PW; Merk FB; Seto HS
Cancer Res; 1988 Feb; 48(3):609-14. PubMed ID: 3257169
[TBL] [Abstract][Full Text] [Related]
6. Variability of androgen-related phenotypes in the Shionogi mammary carcinoma during growth, involution, recurrence, and progression to hormonal independence.
Bruchovsky N; Rennie PS; Otal N; Vanson A; Giles M; Pontifex H
Cancer Res; 1985 Feb; 45(2):682-9. PubMed ID: 3967243
[TBL] [Abstract][Full Text] [Related]
7. Expression and localization of androgen receptor in the R-3327 Dunning rat prostatic adenocarcinoma.
Quarmby VE; Beckman WC; Cooke DB; Lubahn DB; Joseph DR; Wilson EM; French FS
Cancer Res; 1990 Feb; 50(3):735-9. PubMed ID: 2404576
[TBL] [Abstract][Full Text] [Related]
8. Androgen receptor gene expression in human prostate carcinoma cell lines.
Tilley WD; Wilson CM; Marcelli M; McPhaul MJ
Cancer Res; 1990 Sep; 50(17):5382-6. PubMed ID: 2386943
[TBL] [Abstract][Full Text] [Related]
9. Effects of androgen withdrawal on the stem cell composition of the Shionogi carcinoma.
Bruchovsky N; Rennie PS; Coldman AJ; Goldenberg SL; To M; Lawson D
Cancer Res; 1990 Apr; 50(8):2275-82. PubMed ID: 2317815
[TBL] [Abstract][Full Text] [Related]
10. Androgen-dependent growth regulation of and release of specific protein(s) by the androgen receptor containing human prostate tumor cell line LNCaP.
Berns EM; de Boer W; Mulder E
Prostate; 1986; 9(3):247-59. PubMed ID: 2946029
[TBL] [Abstract][Full Text] [Related]
11. Androgens inhibit the proliferation of a variant of the human prostate cancer cell line LNCaP.
Joly-Pharaboz MO; Soave MC; Nicolas B; Mebarki F; Renaud M; Foury O; Morel Y; Andre JG
J Steroid Biochem Mol Biol; 1995 Oct; 55(1):67-76. PubMed ID: 7577722
[TBL] [Abstract][Full Text] [Related]
12. In vivo amplification of the androgen receptor gene and progression of human prostate cancer.
Visakorpi T; Hyytinen E; Koivisto P; Tanner M; Keinänen R; Palmberg C; Palotie A; Tammela T; Isola J; Kallioniemi OP
Nat Genet; 1995 Apr; 9(4):401-6. PubMed ID: 7795646
[TBL] [Abstract][Full Text] [Related]
13. Hormone sensitivity of the R3327-G rat prostate adenocarcinoma: growth rate, DNA content, and hormone receptors.
Pollack A; Irvin GL; Block NL; Lipton RM; Stover BJ; Claflin AJ
Cancer Res; 1982 Jun; 42(6):2184-90. PubMed ID: 7074599
[TBL] [Abstract][Full Text] [Related]
14. Differential androgen modulation of AXC/SSh rat prostate cancer cell proliferation in vitro and its antagonism by antiandrogen.
Huot RI; Shain SA
Cancer Res; 1986 Aug; 46(8):3775-81. PubMed ID: 2942235
[TBL] [Abstract][Full Text] [Related]
15. Calcium regulation of androgen receptor expression in the human prostate cancer cell line LNCaP.
Gong Y; Blok LJ; Perry JE; Lindzey JK; Tindall DJ
Endocrinology; 1995 May; 136(5):2172-8. PubMed ID: 7720667
[TBL] [Abstract][Full Text] [Related]
16. Tissue-specific pharmacology of testosterone and 5 alpha-dihydrotestosterone analogues: characterization of a novel canine liver androgen-binding protein.
Summerfield AE; Diaz Cruz PJ; Dolenga MP; Smith HE; Strader CD; Toney JH
Mol Pharmacol; 1995 May; 47(5):1080-8. PubMed ID: 7746275
[TBL] [Abstract][Full Text] [Related]
17. Genome-wide analysis of androgen receptor binding and gene regulation in two CWR22-derived prostate cancer cell lines.
Chen H; Libertini SJ; George M; Dandekar S; Tepper CG; Al-Bataina B; Kung HJ; Ghosh PM; Mudryj M
Endocr Relat Cancer; 2010 Dec; 17(4):857-73. PubMed ID: 20634343
[TBL] [Abstract][Full Text] [Related]
18. Human prostate androgen receptor quantitation: effects of temperature on assay parameters.
Shain SA; Gorelic LS; Boesel RW; Radwin HM; Lamm DL
Cancer Res; 1982 Nov; 42(11):4849-54. PubMed ID: 6982098
[TBL] [Abstract][Full Text] [Related]
19. Androgen increases androgen receptor protein while decreasing receptor mRNA in LNCaP cells.
Krongrad A; Wilson CM; Wilson JD; Allman DR; McPhaul MJ
Mol Cell Endocrinol; 1991 Apr; 76(1-3):79-88. PubMed ID: 1820979
[TBL] [Abstract][Full Text] [Related]
20. Androgenic and antiandrogenic control on epidermal growth factor, epidermal growth factor receptor, and androgen receptor expression in human prostate cancer cell line LNCaP.
Ravenna L; Lubrano C; Di Silverio F; Vacca A; Felli MP; Maroder M; D'Eramo G; Sciarra F; Frati L; Gulino A
Prostate; 1995 Jun; 26(6):290-8. PubMed ID: 7784269
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
